Biosynex SA (ALBIO.PA)
EUR 1.35
(-12.65%)
EUR 1.35
(-12.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 92.97 Million | 196.58 Million | 382.53 Million | 153.89 Million | 34.23 Million | 31.29 Million |
| Cost of Revenue | 43.84 Million | 132.06 Million | 199.97 Million | 105.79 Million | 32.37 Million | 22.54 Million |
| Gross Profit | 49.13 Million | 64.52 Million | 182.55 Million | 48.09 Million | 1.85 Million | 8.75 Million |
| Operating Expenses | 86.53 Million | 25.65 Million | 41.89 Million | 2.36 Million | 750.75 Thousand | 8.24 Million |
| Selling, General and Administrative Expenses | 36.06 Million | 34.19 Million | 38.6 Million | 15.32 Million | 62.62 Thousand | 7.31 Million |
| Research and Development Expenses | 3.91 Million | 2.85 Million | - | - | - | - |
| Other Expenses | 46.55 Million | 8.54 Million | -3.29 Million | 12.96 Million | -688.13 Thousand | -62.79 Thousand |
| Cost and Expenses | 130.38 Million | 157.72 Million | 241.87 Million | 108.16 Million | 33.12 Million | 30.78 Million |
| Operating Income | -37.4 Million | 38.86 Million | 140.65 Million | 45.73 Million | 1.1 Million | 371.75 Thousand |
| Interest Expense | 2.63 Million | 559.27 Thousand | 365.47 Thousand | 285.96 Thousand | 190 Thousand | 199.61 Thousand |
| Income Tax Expense | -2.55 Million | 8.57 Million | 32.93 Million | 12.14 Million | -215.73 Thousand | 171.49 Thousand |
| Earnings before Tax | -39.67 Million | 29.8 Million | 139.62 Million | 44.37 Million | 899.9 Thousand | 371.39 Thousand |
| Net Income | -36.94 Million | 15.65 Million | 104 Million | 31.36 Million | 1.09 Million | 542.89 Thousand |
| Earnings Per Share Basic | -3.45 | 1.52 | 10.08 | 3.43 | 0.12 | 0.06 |
| Earnings Per Share Diluted | -3.45 | 1.52 | 10.01 | 3.05 | 0.12 | 0.06 |
| Weighted Average Shares Outstanding | 10.7 Million | 10.25 Million | 10.31 Million | 9.15 Million | 9.13 Million | 9.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.7 Million | 10.27 Million | 10.39 Million | 10.29 Million | 9.13 Million | 9.13 Million |
| Gross Margin | 0.53 | 0.33 | 0.48 | 0.31 | 0.05 | 0.28 |
| EBIT Margin | -0.11 | 0.28 | 0.38 | 0.34 | 0.05 | 0.03 |
| Profit Margin | -0.40 | 0.08 | 0.27 | 0.20 | 0.03 | 0.02 |
| EBITDA | -10.18 Million | 46.72 Million | 146.59 Million | 51.29 Million | 1.64 Million | 838.87 Thousand |
| Earnings Before Tax Margin | -0.40 | 0.20 | 0.37 | 0.30 | 0.03 | 0.01 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 53.7 Million | 50.32 Million | 92.97 Million | 42.65 Million | 196.58 Million | 54.34 Million |
| Cost of Revenue | 64.3 Million | 24.66 Million | 43.84 Million | 52.98 Million | 132.06 Million | 49.54 Million |
| Gross Profit | -10.6 Million | 25.66 Million | 49.13 Million | -10.33 Million | 64.52 Million | 4.8 Million |
| Operating Expenses | 500 Thousand | 63.06 Million | 81.87 Million | 7.5 Million | 25.65 Million | 12.89 Million |
| Selling, General and Administrative Expenses | - | 19.34 Million | - | 18.28 Million | - | 17.02 Million |
| Research and Development Expenses | - | 1.39 Million | - | 2.52 Million | - | 1.83 Million |
| Other Expenses | -500 Thousand | 42.32 Million | 15.33 Million | 10.78 Million | 8.54 Million | 4.12 Million |
| Cost and Expenses | 64.8 Million | 87.72 Million | 125.72 Million | 60.48 Million | 157.72 Million | 62.44 Million |
| Operating Income | -11.1 Million | -37.4 Million | -37.4 Million | -17.83 Million | 38.86 Million | -8.09 Million |
| Interest Expense | 1.7 Million | - | 2.07 Million | 1.36 Million | 559.27 Thousand | 327.58 Thousand |
| Income Tax Expense | 100 Thousand | 1.97 Million | -2.55 Million | -578 Thousand | 8.57 Million | -2.84 Million |
| Earnings before Tax | - | -19.74 Million | -38.16 Million | -18.41 Million | 29.8 Million | -16.04 Million |
| Net Income | -21 Million | -17.55 Million | -36.94 Million | -19.39 Million | 15.65 Million | -14.97 Million |
| Earnings Per Share Basic | -1.94 | -1.54 | - | -1.89 | - | -1.46 |
| Earnings Per Share Diluted | -1.94 | -1.54 | - | -1.89 | - | -1.45 |
| Weighted Average Shares Outstanding | 10.81 Million | 11.42 Million | 10.7 Million | 10.25 Million | 10.25 Million | 10.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.81 Million | 11.42 Million | 10.7 Million | 10.25 Million | 10.27 Million | 10.32 Million |
| Gross Margin | -0.20 | 0.51 | 0.53 | -0.24 | 0.33 | 0.09 |
| EBIT Margin | -0.21 | -0.28 | - | -0.02 | - | 0.04 |
| Profit Margin | -0.39 | -0.35 | -0.40 | -0.45 | 0.08 | -0.28 |
| EBITDA | -11.5 Million | -14.01 Million | - | -751 Thousand | - | 2.15 Million |
| Earnings Before Tax Margin | -0.21 | -0.74 | -0.40 | -0.42 | 0.20 | -0.15 |
7022
EPG-R
LMDCF
LUCRF
ALINS
RPTECH